ETRACS Monthly Pay 2xLeveraged S&P Dividend ETN
SDYL
SDYL was delisted on the 20th of November, 2020.
3 hedge funds and large institutions have $984K invested in ETRACS Monthly Pay 2xLeveraged S&P Dividend ETN in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
42% more capital invested
Capital invested by funds: $692K → $984K (+$292K)
25% less funds holding
Funds holding: 4 → 3 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$158K |
| 2 |
Jane Street
New York
|
+$49.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9K |
SDYL Hedge Fund Activity: Q4 2015 in Review
3 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in ETRACS Monthly Pay 2xLeveraged S&P Dividend ETN (SDYL) for Q4 2015, worth a combined $984K — up 42% from $692K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SDYL and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was Sigma Planning Corp, adding an estimated $158K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $9K sold.
- 3 institutional investors held ETRACS Monthly Pay 2xLeveraged S&P Dividend ETN (SDYL) as of Q4 2015, down from 4 in Q3 2015.
- Funds reported $984K of ETRACS Monthly Pay 2xLeveraged S&P Dividend ETN stock for Q4 2015, up 42% quarter-over-quarter.
- 0 funds opened new ETRACS Monthly Pay 2xLeveraged S&P Dividend ETN positions in Q4 2015 and 1 closed out, a net change of -1 holder.
- The largest ETRACS Monthly Pay 2xLeveraged S&P Dividend ETN buyer in Q4 2015 was Sigma Planning Corp, an estimated $158K added.
- The largest ETRACS Monthly Pay 2xLeveraged S&P Dividend ETN seller in Q4 2015 was Tower Research Capital (TRC), an estimated $9K sold.
Based on aggregated 13F filings for Q4 2015.